{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:26:54Z","timestamp":1791044814740,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T00:00:00Z","timestamp":1551312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s12282-019-00955-6","type":"journal-article","created":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T11:44:36Z","timestamp":1551354276000},"page":"552-561","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["The clinical impact of MRI screening for BRCA mutation carriers: the first report in Japan"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7956-6052","authenticated-orcid":false,"given":"Wakana","family":"Murakami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Tozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seigo","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimi","family":"Ide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuko","family":"Inuzuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouzou","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noritsugu","family":"Takahama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimitsu","family":"Ohgiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiko","family":"Gokan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,28]]},"reference":[{"key":"955_CR1","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1111\/j.1349-7006.2008.00944.x","volume":"99","author":"K Sugano","year":"2008","unstructured":"Sugano K, Nakamura S, Ando J, Takayama S, Kamata H, Sekiguchi I, et al. Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast\/ovarian cancer. Cancer Sci. 2008;99:1967\u201376.","journal-title":"Cancer Sci"},{"key":"955_CR2","doi-asserted-by":"publisher","first-page":"920","DOI":"10.2214\/AJR.16.16957","volume":"209","author":"SM Ha","year":"2017","unstructured":"Ha SM, Chae EY, Cha JH, Kim HH, Shin HJ, Choi WJ. Association of BRCA mutation types, imaging features, and pathologic findings in patients with breast cancer with BRCA1 and BRCA2 mutations. Am J Roentgenol. 2017;209:920\u20138.","journal-title":"Am J Roentgenol"},{"key":"955_CR3","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s10549-017-4198-4","volume":"163","author":"J Krammer","year":"2017","unstructured":"Krammer J, Pinker-Domenig K, Robson ME, G\u00f6nen M, Bernard-Davila B, Morris EA, et al. Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat. 2017;163:565\u201371.","journal-title":"Breast Cancer Res Treat"},{"key":"955_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3322\/canjclin.57.2.75","volume":"57","author":"D Saslow","year":"2007","unstructured":"Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75\u201389.","journal-title":"CA Cancer J Clin"},{"key":"955_CR5","volume-title":"ACR BI- RADS Atlas","author":"American College of Radiology","year":"2013","unstructured":"American College of Radiology. ACR BI- RADS Atlas. 5th ed. Reston: American College of Radiology; 2013.","edition":"5"},{"key":"955_CR6","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"955_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2463\/mrms.cr.2016-0090","volume":"16","author":"M Tozaki","year":"2017","unstructured":"Tozaki M, Nakamura S, Kitagawa D, Iwase T, Horii R, Akiyama F, et al. Ductal carcinoma in situ detected during prospective MR imaging screening of a woman with a BRCA2 mutation: the first case report in Japan. Magn Reson Med Sci. 2017;16:265\u20139.","journal-title":"Magn Reson Med Sci"},{"key":"955_CR8","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1200\/JCO.2009.23.0839","volume":"28","author":"C Kuhl","year":"2010","unstructured":"Kuhl C, Weigel S, Schrading S, Arand B, Bieling H, K\u00f6nig R, et al. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J Clin Oncol. 2010;28:1450\u20137.","journal-title":"J Clin Oncol"},{"key":"955_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s12282-008-0074-8","volume":"16","author":"M Tozaki","year":"2009","unstructured":"Tozaki M, Yamashiro N, Suzuki T, Kawano N, Ozaki S, Sakamoto N, et al. MR-guided vacuum-assisted breast biopsy: is it an essential technique? Breast Cancer. 2009;16:121\u20135.","journal-title":"Breast Cancer"},{"key":"955_CR10","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s11604-010-0464-7","volume":"28","author":"M Tozaki","year":"2010","unstructured":"Tozaki M, Yamashiro N, Sakamoto M, Sakamoto N, Mizuuchi N, Fukuma E. Magnetic resonance-guided vacuum-assisted breast biopsy: results in 100 Japanese women. Jpn J Radiol. 2010;28:527\u201333.","journal-title":"Jpn J Radiol"},{"key":"955_CR11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s12282-009-0112-1","volume":"17","author":"N Sakamoto","year":"2010","unstructured":"Sakamoto N, Tozaki M, Higa K, Abe S, Ozaki S, Fukuma E. False-negative ultrasound-guided vacuum-assisted biopsy of the breast: difference with US-detected and MRI-detected lesions. Breast Cancer. 2010;17:110\u20137.","journal-title":"Breast Cancer"},{"key":"955_CR12","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1002\/cncr.22176","volume":"107","author":"JC Boughey","year":"2006","unstructured":"Boughey JC, Khakpour N, Meric-Bernstam F, Ross MI, Kuerer HM, Singletary SE, et al. Selective use of sentinel lymph node surgery during prophylactic mastectomy. Cancer. 2006;107:1440\u20137.","journal-title":"Cancer"},{"key":"955_CR13","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1056\/NEJMoa065447","volume":"356","author":"CD Lehman","year":"2007","unstructured":"Lehman CD, Gatsonis C, Kuhl CK, Hendrick RE, Pisano ED, Hanna L, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007;356:1295\u2013303.","journal-title":"N Engl J Med"},{"key":"955_CR14","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1148\/radiol.2433060838","volume":"243","author":"F Pediconi","year":"2007","unstructured":"Pediconi F, Catalano C, Roselli A, Padula S, Altomari F, Moriconi E, et al. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions. Radiology. 2007;243:670\u201380.","journal-title":"Radiology"},{"key":"955_CR15","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1158\/1078-0432.CCR-15-0459","volume":"22","author":"F Podo","year":"2016","unstructured":"Podo F, Santoro F, Di Leo G, Manoukian S, De Giacomi C, Corcione S, et al. Triple-negative versus non-triple-negative breast cancers in high-risk women: phenotype features and survival from the HIBCRIT-1 MRI-including screening study. Clin Cancer Res. 2016;22:895\u2013904.","journal-title":"Clin Cancer Res"},{"key":"955_CR16","doi-asserted-by":"publisher","first-page":"5265","DOI":"10.1200\/JCO.2009.27.2294","volume":"28","author":"AJ Rijnsburger","year":"2010","unstructured":"Rijnsburger AJ, Obdeijn IM, Kaas R, Tilanus-Linthorst MMA, Boetes C, Loo CE, et al. BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC screening study. J Clin Oncol. 2010;28:5265\u201373.","journal-title":"J Clin Oncol"},{"key":"955_CR17","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s12282-013-0503-1","volume":"22","author":"S Nakamura","year":"2015","unstructured":"Nakamura S, Takahashi M, Tozaki M, Nakayama T, Nomizu T, Miki Y, et al. Prevalence and differentiation of hereditary breast and ovarian cancers in Japan. Breast Cancer. 2015;22:462\u20138.","journal-title":"Breast Cancer"},{"key":"955_CR18","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1148\/radiol.2017170458","volume":"286","author":"S Vreemann","year":"2018","unstructured":"Vreemann S, Gubern-M\u00e9rida A, Schlooz-Vries MS, Bult P, van Gils CH, Hoogerbrugge N, et al. Influence of risk category and screening round on the performance of an MR imaging and mammography screening program in carriers of the BRCA mutation and other women at increased risk. Radiology. 2018;286:443\u201351.","journal-title":"Radiology"},{"key":"955_CR19","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips K-A, Mooij TM, Roos-Blom M-J, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317:2402\u201316.","journal-title":"JAMA"},{"key":"955_CR20","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1148\/radiol.2461062173","volume":"246","author":"S Schrading","year":"2008","unstructured":"Schrading S, Kuhl CK. Mammographic, US, and MR imaging phenotypes of familial breast cancer. Radiology. 2008;246:58\u201370.","journal-title":"Radiology"},{"key":"955_CR21","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa031759","volume":"351","author":"M Kriege","year":"2004","unstructured":"Kriege M, Brekelmans CTM, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med. 2004;351:427\u201337.","journal-title":"N Engl J Med"},{"key":"955_CR22","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1148\/radiol.2423051965","volume":"242","author":"F Sardanelli","year":"2007","unstructured":"Sardanelli F, Podo F, D\u2019Agnolo G, Verdecchia A, Santaquilani M, Musumeci R, et al. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. Radiology. 2007;242:698\u2013715.","journal-title":"Radiology"},{"key":"955_CR23","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1002\/cncr.26424","volume":"118","author":"KP Lowry","year":"2012","unstructured":"Lowry KP, Lee JM, Kong CY, McMahon PM, Gilmore ME, Cott Chubiz JE, et al. Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: a comparative effectiveness analysis. Cancer. 2012;118:2021\u201330.","journal-title":"Cancer"},{"key":"955_CR24","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/bjc.2016.32","volume":"114","author":"X Phi","year":"2016","unstructured":"Phi X, Saadatmand S, De Bock GH, Warner E, Sardanelli F, Leach MO, et al. Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis. Br J Cancer. 2016;114:631\u20137.","journal-title":"Br J Cancer"},{"key":"955_CR25","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s10552-006-0026-6","volume":"17","author":"AB Crest","year":"2006","unstructured":"Crest AB, Aiello EJ, Anderson ML, Buist DSM. Varying levels of family history of breast cancer in relation to mammographic breast density (United States). Cancer Causes Control. 2006;17:843\u201350.","journal-title":"Cancer Causes Control"},{"key":"955_CR26","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1007\/s12282-017-0763-2","volume":"24","author":"T Sawada","year":"2017","unstructured":"Sawada T, Akashi S, Nakamura S, Kuwayama T, Enokido K, Yoshida M, et al. Digital volumetric measurement of mammographic density and the risk of overlooking cancer in Japanese women. Breast Cancer. 2017;24:708\u201313.","journal-title":"Breast Cancer"},{"key":"955_CR27","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/S1470-2045(05)70390-9","volume":"6","author":"NF Boyd","year":"2005","unstructured":"Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, et al. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol. 2005;6:798\u2013808.","journal-title":"Lancet Oncol"},{"key":"955_CR28","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1093\/aje\/kwi270","volume":"162","author":"G Maskarinec","year":"2005","unstructured":"Maskarinec G, Pagano I, Lurie G, Wilkens LR, Kolonel LN. Mammographic density and breast cancer risk: the multiethnic cohort study. Am J Epidemiol. 2005;162:743\u201352.","journal-title":"Am J Epidemiol"},{"key":"955_CR29","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1093\/ije\/dyu042","volume":"43","author":"H Dai","year":"2014","unstructured":"Dai H, Yan Y, Wang P, Liu P, Cao Y, Xiong L, et al. Distribution of mammographic density and its influential factors among Chinese women. Int J Epidemiol. 2014;43:1240\u201351.","journal-title":"Int J Epidemiol"},{"key":"955_CR30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13058-018-1025-8","volume":"20","author":"D Puliti","year":"2018","unstructured":"Puliti D, Zappa M, Giorgi Rossi P, Pierpaoli E, Manneschi G, Ambrogetti D, et al. Volumetric breast density and risk of advanced cancers after a negative screening episode: a cohort study. Breast Cancer Res. 2018;20:95.","journal-title":"Breast Cancer Res"},{"key":"955_CR31","doi-asserted-by":"publisher","first-page":"8469","DOI":"10.1200\/JCO.2004.00.4960","volume":"23","author":"CK Kuhl","year":"2005","unstructured":"Kuhl CK, Schrading S, Leutner CC, Morakkabati-Spitz N, Wardelmann E, Fimmers R, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol. 2005;23:8469\u201376.","journal-title":"J Clin Oncol"},{"key":"955_CR32","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.292.11.1317","volume":"292","author":"E Warner","year":"2004","unstructured":"Warner E, Plewes DB, Hill KA, Causer PA, Zubovits JT, Jong RA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA. 2004;292:1317\u201325.","journal-title":"JAMA"},{"key":"955_CR33","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1148\/radiol.2442060461","volume":"244","author":"CD Lehman","year":"2007","unstructured":"Lehman CD, Isaacs C, Schnall MD, Pisano ED, Ascher SM, Weatherall PT, et al. Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. Radiology. 2007;244:381\u20138.","journal-title":"Radiology"},{"key":"955_CR34","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13058-018-1019-6","volume":"20","author":"S Vreemann","year":"2018","unstructured":"Vreemann S, van Zelst JCM, Schlooz-Vries M, Bult P, Hoogerbrugge N, Karssemeijer N, et al. The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI. Breast Cancer Res. 2018;20:84.","journal-title":"Breast Cancer Res"},{"key":"955_CR35","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0140-6736(07)61232-X","volume":"370","author":"CK Kuhl","year":"2007","unstructured":"Kuhl CK, Schrading S, Bieling HB, Wardelmann E, Leutner CC, Koenig R, et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet. 2007;370:485\u201392.","journal-title":"Lancet"},{"key":"955_CR36","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1148\/radiol.2017161218","volume":"285","author":"JCM Zelst van","year":"2017","unstructured":"van Zelst JCM, Mus RDM, Woldringh G, Rutten MJCM, Bult P, Vreemann S, et al. Surveillance of women with the BRCA 1 or BRCA 2 mutation by using biannual automated breast US, MR imaging, and mammography. Radiology. 2017;285:376\u201388.","journal-title":"Radiology"},{"key":"955_CR37","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s10549-016-3912-y","volume":"158","author":"AK Narayan","year":"2016","unstructured":"Narayan AK, Visvanathan K, Harvey SC. Comparative effectiveness of breast MRI and mammography in screening young women with elevated risk of developing breast cancer: a retrospective cohort study. Breast Cancer Res Treat. 2016;158:583\u20139.","journal-title":"Breast Cancer Res Treat"},{"key":"955_CR38","doi-asserted-by":"publisher","first-page":"e5660","DOI":"10.1136\/bmj.e5660","volume":"345","author":"A Pijpe","year":"2012","unstructured":"Pijpe A, Andrieu N, Easton DF, Kesminiene A, Cardis E, Nogu\u00e8s C, et al. Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1\/2 mutations: retrospective cohort study (GENE-RAD-RISK). BMJ. 2012;345:e5660.","journal-title":"BMJ"},{"key":"955_CR39","doi-asserted-by":"publisher","first-page":"e0116344","DOI":"10.1371\/journal.pone.0116344","volume":"10","author":"WH Kim","year":"2015","unstructured":"Kim WH, Han W, Chang JM, Cho N, Park IA, Moon WK. Location of triple-negative breast cancers: comparison with estrogen receptor-positive breast cancers on MR imaging. PLoS One. 2015;10:e0116344.","journal-title":"PLoS One"},{"key":"955_CR40","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/cncr.21720","volume":"106","author":"C Perlet","year":"2006","unstructured":"Perlet C, Heywang-Kobrunner SH, Heinig A, Sittek H, Casselman J, Anderson I, et al. Magnetic resonance-guided, vacuum-assisted breast biopsy: results from a European multicenter study of 538 lesions. Cancer. 2006;106:982\u201390.","journal-title":"Cancer"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12282-019-00955-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-019-00955-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-019-00955-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T19:28:35Z","timestamp":1582831715000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12282-019-00955-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,28]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["955"],"URL":"https:\/\/doi.org\/10.1007\/s12282-019-00955-6","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,28]]},"assertion":[{"value":"22 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Our study received IRB approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}